The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global High-end Cellomics Market Research Report 2024

Global High-end Cellomics Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1766175

No of Pages : 67

Synopsis
"High-end Cellomics" is a term that combines "high-end" technology with "cellomics," which refers to the study of cellular components and functions using advanced imaging and analysis techniques. In the context of high-end cellomics, it typically refers to the use of sophisticated and advanced technologies for cellular analysis, imaging, and high-content screening.

Global High-end Cellomics market is projected to reach US$ 487.7 million in 2029, increasing from US$ 294 million in 2022, with the CAGR of 7.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole High-end Cellomics market research.

Key companies engaged in the High-end Cellomics industry include PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation and Merck, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of High-end Cellomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole High-end Cellomics market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global High-end Cellomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Merck

Segment by Type

  • Basic Research
  • Drug Discovery

Segment by Application

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Independent Contract Research Organizations (CROs)

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The High-end Cellomics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-end Cellomics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Basic Research
1.2.3 Drug Discovery
1.3 Market by Application
1.3.1 Global High-end Cellomics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Independent Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-end Cellomics Market Perspective (2018-2029)
2.2 High-end Cellomics Growth Trends by Region
2.2.1 Global High-end Cellomics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 High-end Cellomics Historic Market Size by Region (2018-2023)
2.2.3 High-end Cellomics Forecasted Market Size by Region (2024-2029)
2.3 High-end Cellomics Market Dynamics
2.3.1 High-end Cellomics Industry Trends
2.3.2 High-end Cellomics Market Drivers
2.3.3 High-end Cellomics Market Challenges
2.3.4 High-end Cellomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-end Cellomics Players by Revenue
3.1.1 Global Top High-end Cellomics Players by Revenue (2018-2023)
3.1.2 Global High-end Cellomics Revenue Market Share by Players (2018-2023)
3.2 Global High-end Cellomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by High-end Cellomics Revenue
3.4 Global High-end Cellomics Market Concentration Ratio
3.4.1 Global High-end Cellomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-end Cellomics Revenue in 2022
3.5 High-end Cellomics Key Players Head office and Area Served
3.6 Key Players High-end Cellomics Product Solution and Service
3.7 Date of Enter into High-end Cellomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 High-end Cellomics Breakdown Data by Type
4.1 Global High-end Cellomics Historic Market Size by Type (2018-2023)
4.2 Global High-end Cellomics Forecasted Market Size by Type (2024-2029)
5 High-end Cellomics Breakdown Data by Application
5.1 Global High-end Cellomics Historic Market Size by Application (2018-2023)
5.2 Global High-end Cellomics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America High-end Cellomics Market Size (2018-2029)
6.2 North America High-end Cellomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America High-end Cellomics Market Size by Country (2018-2023)
6.4 North America High-end Cellomics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High-end Cellomics Market Size (2018-2029)
7.2 Europe High-end Cellomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe High-end Cellomics Market Size by Country (2018-2023)
7.4 Europe High-end Cellomics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High-end Cellomics Market Size (2018-2029)
8.2 Asia-Pacific High-end Cellomics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific High-end Cellomics Market Size by Region (2018-2023)
8.4 Asia-Pacific High-end Cellomics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High-end Cellomics Market Size (2018-2029)
9.2 Latin America High-end Cellomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America High-end Cellomics Market Size by Country (2018-2023)
9.4 Latin America High-end Cellomics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-end Cellomics Market Size (2018-2029)
10.2 Middle East & Africa High-end Cellomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa High-end Cellomics Market Size by Country (2018-2023)
10.4 Middle East & Africa High-end Cellomics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PerkinElmer, Inc.
11.1.1 PerkinElmer, Inc. Company Detail
11.1.2 PerkinElmer, Inc. Business Overview
11.1.3 PerkinElmer, Inc. High-end Cellomics Introduction
11.1.4 PerkinElmer, Inc. Revenue in High-end Cellomics Business (2018-2023)
11.1.5 PerkinElmer, Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Detail
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. High-end Cellomics Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in High-end Cellomics Business (2018-2023)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Detail
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation High-end Cellomics Introduction
11.3.4 Danaher Corporation Revenue in High-end Cellomics Business (2018-2023)
11.3.5 Danaher Corporation Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck High-end Cellomics Introduction
11.4.4 Merck Revenue in High-end Cellomics Business (2018-2023)
11.4.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’